Showing results (1301-1310 of 1,919) with videos related to

Sort By:
Pageof 192
Scientific Reports|October 29, 2025
Trust in institutions and misinformation susceptibility both independently explain vaccine skepticismThom Roozenbeek, Caspar van den Berg, Mattijs S Lambooij, et al.
Journal of Virology|October 4, 2013
First insights into the entry process of hyperthermophilic archaeal virusesEmmanuelle R J Quemin, Soizick Lucas, Bertram Daum, et al.
European Journal of Human Genetics : EJHG|November 24, 2020
Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participantsLiis Leitsalu, Marili Palover, Timo Tõnis Sikka, et al.
Scientific Reports|August 22, 2018
DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boostPontus Öhlund, Juan García-Arriaza, Eva Zusinaite, et al.
Nature Communications|June 14, 2024
Two distinct archaeal type IV pili structures formed by proteins with identical sequenceJunfeng Liu, Gunnar N Eastep, Virginija Cvirkaite-Krupovic, et al.
Nucleic Acids Research|May 28, 2026
A pair of DNA glucosyltransferases elevate counter-defense in bacteriophage T4Luis Ramirez-Chamorro, Frédéric Bonhomme, Anton Lukas Ipsen Wolff, et al.
Environmental Microbiology|March 29, 2019
Novel haloarchaeal viruses from Lake Retba infecting Haloferax and Halorubrum speciesCarolina M Mizuno, Bina Prajapati, Soizick Lucas-Staat, et al.
Health Policy (Amsterdam, Netherlands)|June 30, 2012
Choosing pandemic parameters for pandemic preparedness planning: a comparison of pandemic scenarios prior to and following the influenza A(H1N1) 2009 pandemicCharlie P van der Weijden, Mart L Stein, André J Jacobi, et al.
Veterinary Immunology and Immunopathology|March 29, 2023
Immunoadjuvant efficacy of CpG plasmids for H9N2 avian influenza inactivated vaccine in chickens with maternal antibodiesXue Pan, Qinfang Liu, Mart C M de Jong, et al.
Pageof 192